Correlation Between CorMedix and Axon Enterprise
Can any of the company-specific risk be diversified away by investing in both CorMedix and Axon Enterprise at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CorMedix and Axon Enterprise into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CorMedix and Axon Enterprise, you can compare the effects of market volatilities on CorMedix and Axon Enterprise and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CorMedix with a short position of Axon Enterprise. Check out your portfolio center. Please also check ongoing floating volatility patterns of CorMedix and Axon Enterprise.
Diversification Opportunities for CorMedix and Axon Enterprise
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CorMedix and Axon is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding CorMedix and Axon Enterprise in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axon Enterprise and CorMedix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CorMedix are associated (or correlated) with Axon Enterprise. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axon Enterprise has no effect on the direction of CorMedix i.e., CorMedix and Axon Enterprise go up and down completely randomly.
Pair Corralation between CorMedix and Axon Enterprise
Given the investment horizon of 90 days CorMedix is expected to generate 69.44 times less return on investment than Axon Enterprise. But when comparing it to its historical volatility, CorMedix is 1.66 times less risky than Axon Enterprise. It trades about 0.01 of its potential returns per unit of risk. Axon Enterprise is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest 42,350 in Axon Enterprise on September 1, 2024 and sell it today you would earn a total of 22,346 from holding Axon Enterprise or generate 52.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.45% |
| Values | Daily Returns |
CorMedix vs. Axon Enterprise
Performance |
| Timeline |
| CorMedix |
| Axon Enterprise |
CorMedix and Axon Enterprise Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CorMedix and Axon Enterprise
The main advantage of trading using opposite CorMedix and Axon Enterprise positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CorMedix position performs unexpectedly, Axon Enterprise can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axon Enterprise will offset losses from the drop in Axon Enterprise's long position.| CorMedix vs. Tarsus Pharmaceuticals | CorMedix vs. Aldeyra | CorMedix vs. Travere Therapeutics | CorMedix vs. Eton Pharmaceuticals |
| Axon Enterprise vs. Novocure | Axon Enterprise vs. HubSpot | Axon Enterprise vs. DigitalOcean Holdings | Axon Enterprise vs. Appian Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |